Novartis AG

Common Name

Novartis

Country

Switzerland

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

103,000

Ticker

NOVN

Exchange

SIX SWISS EXCHANGE

Website

www.novartis.com

Description

Novartis AG is a global healthcare company that operates in the pharmaceuticals and biotechnology sectors. Its primary function is to research, develop, and manufacture healthcare products, with a foc... Show more

Financial Statements of Novartis

Below are the financial statements of Novartis, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of USD	2024	2023
Non-current assets	—	—
Property, plant and equipment	9.46^a	9.51^a
Right-of-use assets	1.42^a	1.41^a
Goodwill	24.76^a	23.34^a
Intangible assets other than goodwill	26.92^a	26.88^a
Investments in associated companies	0.12^a	0.21^a
Deferred tax assets	4.36^a	4.31^a
Financial assets	2.02^a	2.61^a
Other non-current assets	3.51^a	1.2^a
Total non-current assets	72.54^a	69.46^a
Current assets	—	—
Inventories	5.72^a	5.91^a
Trade receivables	7.42^a	7.11^a
Income tax receivables	0.13^a	0.43^a
Marketable securities, commodities, time deposits and derivative financial instruments	2^a	1.04^a
Cash and cash equivalents	11.46^a	13.39^a
Other current assets	2.97^a	2.61^a
Total current assets	29.7^a	30.48^a
Total assets	102.25^a	99.95^a
Equity	—	—
Share capital	0.79^a	0.83^a
Treasury shares	-0.05^a	-0.04^a
Reserves	43.31^a	45.88^a
Equity attributable to Novartis AG shareholders	44.05^a	46.67^a
Non-controlling interests	0.08^a	0.08^a
Total equity	44.13^a	46.75^a
Non-current liabilities	—	—
Financial debts	21.37^a	18.44^a
Lease liabilities	1.57^a	1.6^a
Deferred tax liabilities	2.42^a	2.25^a
Provisions and other non-current liabilities	4.08^a	4.52^a
Total non-current liabilities	29.43^a	26.81^a
Current liabilities	—	—
Trade payables	4.57^a	4.93^a
Financial debts and derivative financial instruments	8.23^a	6.18^a
Lease liabilities	0.24^a	0.23^a
Current income tax liabilities	1.6^a	1.89^a
Provisions and other current liabilities	14.05^a	13.17^a
Total current liabilities	28.69^a	26.39^a
Total liabilities	58.12^a	53.2^a
Total equity and liabilities	102.25^a	99.95^a

Download Data

Verified Sources Behind Novartis’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Novartis’s data sources below and access millions more through our Disclosure Search.

a. Novartis's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Novartis AG

Financial Statements of Novartis

Verified Sources Behind Novartis’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Roche Holding AG

Lonza Group AG

Tecan Group AG

BeOne Medicines AG

Galenica AG

Straumann Holding AG